The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization

Table 1

Comparison of pretreatment and posttreatment measurements of ICNV.

	Pretreatment	1-day posttreatment	1-month posttreatment				value
BCVA letter ()	59.29 ± 14.80	—	66.11 ± 10.86	−1.533			0.135
Selected CNV area (mm^2)	0.41 ± 0.43	0.33 ± 0.38	0.19 ± 0.25	4.559	3.591	4.182	<0.01	<0.01	<0.01
Flow area (mm^2)	0.19 ± 0.19	0.14 ± 0.17	0.09 ± 0.11	5.775	2.832	4.249	<0.01	<0.05	<0.01

BCVA, best corrected visual acuity; CNV, choroidal neovascularization; Comparing pretreatment to 1-day posttreatment measurements; Comparing 1-day to 1-month posttreatment measurements; Comparing pretreatment to 1-month posttreatment measurements.